Compound Radar

Medtronic plc (MDT) Stock Analysis

Price $93.95
Market cap $120.18B
Next earnings Nov 17, 2026
Entry status Good Entry

Last updated Oct 27, 2026

Published Opportunity

This stock was published as a Compound Radar opportunity on Sep 14, 2026. Performance is tracked publicly from the original signal.

Full track record →
Entry $90.96
Return +3.3%
QQQ -0.4%
Alpha vs QQQ +3.7%

Health Check

Last analyzed Oct 23, 2026

68
68/100 High Quality
  • Financial Health 75
  • Profitability 60
  • Business Quality 80
  • Balance Sheet 55
  • Cash Flow 60

Why this rating?

Health 68/100 — High Quality

Strongest Business Quality 80/100
Softest Balance Sheet 55/100
Good Entry

A usable setup — not as clean as Strong Entry, but timing is not mixed or weak.

Company overview

Medtronic plc (MDT) is a Medical Devices company in the Healthcare sector. Compound Radar rates Medtronic plc 68/100 (High Quality) due to high business quality, steady revenue growth, and manageable leverage.

Investment profile

  • Quality High
  • Growth Moderate
  • Balance Sheet Adequate
  • Valuation Attractive

Financial highlights

Valuation

  • P/E 23.25
  • Forward P/E 14.67
  • PEG 1.7
  • EV/Revenue 3.76

Profitability

  • Revenue Growth 13.7%
  • Gross Margin 65.3%
  • Operating Margin 19.3%
  • Net Margin 13.9%
  • ROE 10.6%

Financial strength

  • Cash $8.82B
  • Debt $28.15B
  • Net Cash $-19.33B
  • Free Cash Flow $5.43B
  • Current Ratio 2.07

Similar companies

Peers in Medical Devices, ranked by Financial Health.

Company Ticker
Price Current price

Latest quoted price for the name. Helps anchor the setup in today’s market level.

Health Entry

View all in Medical Devices →

FAQ

How Compound Radar scores and tracks Medtronic plc (MDT).

View Methodology & FAQ →